The use of Bifidobacterium lactis CNCM 1-3446 in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants delivered by caesarean section is disclosed.

 
Web www.patentalert.com

< USE OF AN AQUEOUS GRAPE SEED EXTRACT COMBINED WITH AT LEAST ONE FLUORINE SALT TO COMBAT THE FORMATION OR ACCUMULATION OF DENTAL BIOFILM AND COMPOSITIONS COMPRISING SAID COMBINATION

< CALCIUM PHOSPHATE POROUS MATERIAL WITH SMALL AMOUNT OF REMAINING AROMATIC HYDROCARBON

> PROBIOTICS TO REDUCE EPISODES OF DIARRHOEA IN INFANTS BORN BY CAESAREAN SECTION

> NANOPARTICLES COMPRISING A DRUG,ETHYCELLULOSE,AND A BILE SALT
~ 00606